New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
11:32 EDTNSR, PWRD, SHLD, WUBA, QIWI, DB, KERX, SPRD, AZN, ARUNOptions with decreasing implied volatility:
Options with decreasing implied volatility: NSR KERX WUBA ARUN DB SHLD AZN QIWI PWRD SPLS
News For NSR;KERX;WUBA;ARUN;DB;SHLD;AZN;QIWI;PWRD;SPRD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 18, 2015
17:06 EDTQIWIQIWI, Russian post launch joint money transfer service
Subscribe for More Information
15:16 EDTSHLDSears Holdings May weekly volatility increases into Q1 and outlook
Subscribe for More Information
13:38 EDTQIWIQIWI downgraded to Neutral from Buy at Citigroup
Subscribe for More Information
06:58 EDTDBDeutsche Bank co-CEOs won't step down, Reuters reports
Subscribe for More Information
06:13 EDTAZNAstraZeneca to invest $285M in new biologics manufacturing facility in Sweden
AstraZeneca announced that it plans to invest approximately $285M in a new high-tech facility for manufacturing of biological medicines in Södertälje, Sweden. The new plant will be focused on filling and packaging of protein therapeutics. It is anticipated that the new facility will supply medicines for clinical trial programs of AstraZeneca and MedImmune, the company’s global biologics research and development arm, from the end of 2018, and will deliver finished products for commercial use once fully operational by 2019. Södertälje is currently home to AstraZeneca’s largest global tablets and capsules manufacturing facility and is also a launch platform site for the company, with specialist capabilities on-site that allow large-scale production of new medicines, working closely with the research and development organisation. By locating the new manufacturing plant in Södertälje, the company will combine its expertise in biologics with the well-established culture of operational excellence that exists within the Sweden Operations unit. The planned investment will, subject to relevant approvals by the local authorities, create between 150 and 250 highly skilled new roles at AstraZeneca by 2019. The new manufacturing facility in Sweden will support the progression of drug candidates across the main therapy areas and be aligned with investments being made in the current biologics manufacturing centers, such as the expansion in Frederick, Maryland, announced in November.
May 17, 2015
15:49 EDTAZNAstraZeneca reports Movantik shows 'similar' adverse event rate vs. placebo
Subscribe for More Information
May 15, 2015
13:46 EDTSHLDSears Holdings May weekly volatility elevated into Q1 and outlook
Subscribe for More Information
09:31 EDTAZNAmerican Thoracic Society to hold a conference
ATS 2015 Conference is being held in Denver on May 15-20.
May 14, 2015
12:49 EDTQIWIOn The Fly: Top stock stories at midday
The market opened higher amid lower than expected weekly jobless claims, data showing that producer prices fell rather than rose in April and a continued slide in the dollar against the euro. The Dow notched triple digit gains right out of the gate and the averages have moved in a narrow range in morning trading, albeit at near-record levels. ECONOMIC EVENTS: In the U.S., initial jobless claims fell 1K to 264K in the week ended May 9, versus expectations for 273K first-time claims. The weekly data brought the four week moving average to 271.75K, which marks its lowest level in 15 years. The Producer Price Index fell 0.4% in April, with the core PPI reading sliding 0.2%, which missed expectations for both the headline and core PPI figures to have grown 0.1%. After dropping 1.3% yesterday against the euro, the U.S. dollar slid another 0.4% earlier to about $1.14 per euro, bringing its decline to about 7% versus the euro in the past month. COMPANY NEWS: Shares of Avon Products (AVP) were volatile after "PTG Capital Partners" announced via a filing with the SEC that it has submitted an offer to the board of Avon proposing to acquire all of the company's outstanding stock, and outstanding options to acquire such shares, in a recommended cash tender offer at a price per share of $18.75. Shares of Avon spiked initially after the filing, were halted several times due to volatile trading, and came well off their earlier highs as investors questioned the validity of the firm making the purported offer. A source told Dow Jones that the company was treating the purported bid as a hoax and Avon told CNBC that it had no proof PTG exists and that it has not received any offer. Still, Avon remained up about 4% to trade near $6.92 per share in early afternoon trading. MAJOR MOVERS: Among the notable gainers was Russia's QIWI (QIWI), which jumped 12% after the company announced that it has entered into an agreement with Otkritie to acquire the Contact money transfer system and the Rapida payment processing system, which are "highly value accretive" acquisitions according to analysts at JPMorgan. Also higher was China's Ctrip.com (CTRP), which gained 10% and was upgraded at Stifel and Oppenheimer following the company's Q1 results. Among the noteworthy losers was Puma Biotechnology (PBYI), which dropped 18% after data on the company's neratinib drug was disclosed via an abstract for the company's upcoming presentation at the American Society of Clinical Oncology, or ASCO, meeting. Also lower following its earnings report was retailer Kohl's (KSS), which slid over 12%. INDEXES: Near midday, the Dow was up 170.23, or 0.94%, to 18,230.72, the Nasdaq was up 55.96, or 1.12%, to 5,037.65, and the S&P 500 was up 17.10, or 0.81%, to 2,115.58.
09:22 EDTAZNLeerink pharma/biotech analysts hold an analyst/industry conference call
Subscribe for More Information
07:47 EDTQIWIQIWI price target raised to $50 from $38 at JPMorgan
JPMorgan raised its price target for QIWI to $50 from $38 calling the company's acquisition of Contact and Rapida "highly value accretive." The firm also views QIWI's Q1 results a "strong beat." It reiterates an Overweight rating on the stock.
06:36 EDTQIWIQIWI announces acquisition of Contact and Rapida
Subscribe for More Information
06:35 EDTQIWIQIWI says economic slowdown in Russia could have negative effect on company
QIWI said it has started to note the effects of the macroeconomic slowdown in Russia in the second half of 2014 and especially in Q4, which may be long lasting and could have a significant negative effect on both consumer spending and the banking system in Russia and, accordingly, on QIWI's business in the future. The extent of the slowdown, and if that were to result in a full scale banking crisis, is yet to be assessed. QIWI says it does not currently have enough visibility on our Total Adjusted Net Revenue and Adjusted Net Profit in 2015. QIWI reiterates the 2015 guidance based on the current understanding of the macroeconomic situation, which is subject to change.
06:33 EDTQIWIQIWI backs FY15 adjusted net revenue to increase 12%-16%, consensus RUB 10.03B
Subscribe for More Information
06:33 EDTQIWIQIWI reports Q1 adjusted EPS RUR 14.78, consensus RUR 16.16
Reports Q1 adjusted net revenue RUB 2.52B, consensus RUR 2.15B. Reports Q1 Payment adjusted net revenue RUB 1.84B. The total average Net Revenue Yield was 1.59%, an increase of 33 bps as compared with 1.26% in the prior year. The number of active kiosks and terminals was 177,448, an increase of 6% compared with the prior year.
06:04 EDTDBUnivision IPO could launch 'in weeks,' NY Post reports
Subscribe for More Information
05:52 EDTAZNMizuho expects CAR T stocks to be volatile after ASCO abstract
Subscribe for More Information
May 13, 2015
17:24 EDTAZNAstraZeneca to update progress with immuno-oncology pipeline at ASCO
AstraZeneca and MedImmune, the company’s global biologics research and development arm, will demonstrate rapid progress with their combination-focused oncology pipeline at the American Society of Clinical Oncology, or ASCO, Annual Meeting, May 29-June 2. 61 scientific abstracts will be presented at the meeting, reinforcing the significant progress in immuno-oncology through combination therapies and innovative companion diagnostics.
May 12, 2015
07:48 EDTDBStandard & Poor's to hold a summit
Subscribe for More Information
May 11, 2015
07:14 EDTDBDeutsche Bank's head of structured finance leaving bank, Bloomberg reports
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use